ArticleNaunyn-Schmiedeberg's archives of pharmacology2026
Retraction Note: UBE2D3 regulated by WTAP-mediated m6A modification inhibits temozolomide chemosensitivity in glioblastoma.
Jing Bao et al.PubMed ↗Publisher ↗
No numbers read from the abstract.